Limmroth V - Search Results

1

Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells.

Putzki N, Baranwal MK, Tettenborn B, Limmroth V, Kreuzfelder E. Putzki N, et al. Among authors: limmroth v. Eur Neurol. 2010;63(5):311-7. doi: 10.1159/000302687. Epub 2010 May 5. Eur Neurol. 2010. PMID: 20453514

2

Balo's concentric sclerosis demonstrated by contrast MRI.

Kastrup O, Stude P, Limmroth V. Kastrup O, et al. Among authors: limmroth v. Neurology. 2001 Nov 13;57(9):1610. doi: 10.1212/wnl.57.9.1610. Neurology. 2001. PMID: 11706100 No abstract available.

3

High-dose, frequently administered interferon beta.

Limmroth V, Putzki N. Limmroth V, et al. J Neurol Sci. 2005 Apr 15;231(1-2):95-6; author reply 97-9. doi: 10.1016/j.jns.2004.10.020. Epub 2005 Jan 27. J Neurol Sci. 2005. PMID: 15792828 Clinical Trial. No abstract available.

4

Effects of interferon-beta 1a on the hypothalamic-pituitary-adrenal axis, leukocyte distribution and mood states in multiple sclerosis patients: results of a 1-year follow-up study.

Goebel MU, Czolbe F, Becker H, Janssen OE, Schedlowski M, Limmroth V. Goebel MU, et al. Among authors: limmroth v. Eur Neurol. 2005;53(4):182-7. doi: 10.1159/000086344. Epub 2005 Jun 10. Eur Neurol. 2005. PMID: 15947464 Clinical Trial.

5

Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis.

Putzki N, Knipp S, Ramczykowski T, Vago S, Germing U, Diener HC, Limmroth V. Putzki N, et al. Among authors: limmroth v. Mult Scler. 2006 Jun;12(3):363-6. doi: 10.1191/135248506ms1307cr. Mult Scler. 2006. PMID: 16764353

6

CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.

Kumar M, Putzki N, Limmroth V, Remus R, Lindemann M, Knop D, Mueller N, Hardt C, Kreuzfelder E, Grosse-Wilde H. Kumar M, et al. Among authors: limmroth v. J Neuroimmunol. 2006 Nov;180(1-2):178-84. doi: 10.1016/j.jneuroim.2006.08.003. Epub 2006 Sep 29. J Neuroimmunol. 2006. PMID: 17011048

7

Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis.

Limmroth V, Malessa R, Zettl UK, Koehler J, Japp G, Haller P, Elias W, Obhof W, Viehöver A, Meier U, Brosig A, Hasford J, Putzki N, Kalski G, Wernsdörfer C; QUASIMS Study Group. Limmroth V, et al. J Neurol. 2007 Jan;254(1):67-77. doi: 10.1007/s00415-006-0281-1. Epub 2007 Feb 1. J Neurol. 2007. PMID: 17273808 Clinical Trial.

8

Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.

Gartzen K, Limmroth V, Putzki N. Gartzen K, et al. Among authors: limmroth v. Eur J Neurol. 2007 Jun;14(6):e12-3. doi: 10.1111/j.1468-1331.2007.01807.x. Eur J Neurol. 2007. PMID: 17539924 No abstract available.

9

Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients.

Putzki N, Katsarava Z, Vago S, Diener HC, Limmroth V. Putzki N, et al. Among authors: limmroth v. Eur Neurol. 2008;59(3-4):136-42. doi: 10.1159/000111876. Epub 2007 Nov 30. Eur Neurol. 2008. PMID: 18057900

10

Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.

Putzki N, Kumar M, Kreuzfelder E, Grosse-Wilde H, Diener HC, Limmroth V. Putzki N, et al. Among authors: limmroth v. Eur Neurol. 2009;61(1):27-32. doi: 10.1159/000165346. Epub 2008 Oct 24. Eur Neurol. 2009. PMID: 18948697 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page